A detailed history of Ballast, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Ballast, Inc. holds 27,750 shares of PFE stock, worth $718,447. This represents 0.23% of its overall portfolio holdings.

Number of Shares
27,750
Previous 27,248 1.84%
Holding current value
$718,447
Previous $762,000 5.38%
% of portfolio
0.23%
Previous 0.23%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

BUY
$27.7 - $31.39 $13,905 - $15,757
502 Added 1.84%
27,750 $803,000
Q2 2024

Jul 15, 2024

BUY
$25.26 - $29.6 $134,332 - $157,412
5,318 Added 24.25%
27,248 $762,000
Q1 2024

May 06, 2024

BUY
$25.89 - $29.73 $127,301 - $146,182
4,917 Added 28.9%
21,930 $608,000
Q4 2023

Jan 18, 2024

SELL
$26.13 - $33.94 $374,756 - $486,767
-14,342 Reduced 45.74%
17,013 $489,000
Q3 2023

Oct 18, 2023

BUY
$32.09 - $37.51 $106,442 - $124,420
3,317 Added 11.83%
31,355 $1.04 Million
Q2 2023

Jul 19, 2023

BUY
$36.12 - $41.79 $216,105 - $250,029
5,983 Added 27.13%
28,038 $1.03 Million
Q1 2023

Apr 19, 2023

BUY
$39.39 - $51.28 $77,677 - $101,124
1,972 Added 9.82%
22,055 $899,000
Q4 2022

Jan 26, 2023

SELL
$41.75 - $54.5 $30,101 - $39,294
-721 Reduced 3.47%
20,083 $0
Q3 2022

Oct 18, 2022

BUY
$43.76 - $53.42 $2,581 - $3,151
59 Added 0.28%
20,804 $910,000
Q2 2022

Jul 14, 2022

SELL
$46.53 - $55.17 $85,568 - $101,457
-1,839 Reduced 8.14%
20,745 $1.09 Million
Q1 2022

Apr 18, 2022

BUY
$45.75 - $56.69 $74,938 - $92,858
1,638 Added 7.82%
22,584 $1.17 Million
Q4 2021

Jan 18, 2022

SELL
$41.32 - $61.25 $40,410 - $59,902
-978 Reduced 4.46%
20,946 $1.24 Million
Q3 2021

Nov 12, 2021

BUY
$39.25 - $50.42 $75,674 - $97,209
1,928 Added 9.64%
21,924 $942,000
Q2 2021

Aug 04, 2021

BUY
$35.91 - $40.68 $112,865 - $127,857
3,143 Added 18.65%
19,996 $783,000
Q1 2021

May 05, 2021

BUY
$33.49 - $37.77 $147,824 - $166,716
4,414 Added 35.49%
16,853 $610,000
Q4 2020

Jan 21, 2021

SELL
$33.47 - $42.56 $21,822 - $27,749
-652 Reduced 4.98%
12,439 $457,000
Q3 2020

Oct 14, 2020

SELL
$31.75 - $37.25 $68,548 - $80,422
-2,159 Reduced 14.16%
13,091 $480,000
Q2 2020

Aug 11, 2020

BUY
$30.12 - $36.54 $17,590 - $21,339
584 Added 3.98%
15,250 $498,000
Q1 2020

Apr 17, 2020

BUY
$27.03 - $38.62 $53,276 - $76,120
1,971 Added 15.53%
14,666 $478,000
Q4 2019

Jan 14, 2020

BUY
$32.92 - $37.36 $31,899 - $36,201
969 Added 8.26%
12,695 $497,000
Q3 2019

Oct 22, 2019

SELL
$32.49 - $42.13 $12,833 - $16,641
-395 Reduced 3.26%
11,726 $421,000
Q2 2019

Jul 26, 2019

BUY
$36.98 - $41.52 $6,212 - $6,975
168 Added 1.41%
12,121 $525,000
Q1 2019

Apr 30, 2019

BUY
$37.5 - $41.2 $28,462 - $31,270
759 Added 6.78%
11,953 $507,000
Q4 2018

Feb 01, 2019

SELL
$38.47 - $43.86 $82,171 - $93,684
-2,136 Reduced 16.02%
11,194 $489,000
Q3 2018

Nov 02, 2018

BUY
$34.47 - $41.81 $80,211 - $97,291
2,327 Added 21.15%
13,330 $587,000
Q2 2018

Jul 19, 2018

BUY
$32.98 - $35.16 $11,707 - $12,481
355 Added 3.33%
11,003 $399,000
Q1 2018

May 11, 2018

BUY
$31.91 - $37.02 $4,977 - $5,775
156 Added 1.49%
10,648 $378,000
Q4 2017

Feb 12, 2018

BUY
$33.26 - $35.29 $348,963 - $370,262
10,492
10,492 $380,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $145B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Ballast, Inc. Portfolio

Follow Ballast, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ballast, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ballast, Inc. with notifications on news.